The document provides a base of scientific and regulatory knowledge for veterinary practitioners from leading veterinary experts.

Resources to help veterinarians advise clients and treat patients who may have been exposed to marijuana, the most commonly used illicit drug in the…

The hearing is part of an FDA plan resulting from growing interest in FDA-regulated products derived from Cannabis sativa L and its components.

Get answers to frequently asked questions about the regulatory status of cannabis, cannabis-derived, and cannabis-related products in veterinary…

Presentations on the research and regulations concerning the use of cannabis in veterinary medicine will be offered throughout the AVMA Virtual…

A range of issues were covered at the first AVMA Cannabis Symposium, from regulatory and toxicological concerns to the drug’s potential as a…

Download and use these images on your social media platforms to help answer client questions about cannabis and pets.

A comprehensive new report on cannabis in veterinary medicine provides a base of scientific and regulatory knowledge for veterinary practitioners from…

AVMA's first-ever symposium on veterinary cannabis will provide a 360-degree perspective, presented directly by key leaders in research, practice and…

Webinar offers education and guidance on timely topic If you were one of the 800-plus veterinary professionals who attended the AVMA’s recent webinar…

With many states allowing medicinal marijuana use in humans and some allowing recreational use as well, the AVMA believes it is important for members…

More tools to come With many states allowing medicinal marijuana use in humans, and some allowing recreational use as well, it’s important for…

Cannabis is a topic of high interest as a potential therapeutic agent for both people and animals. Veterinarians continue to field questions from…

The FDA plan features a public hearing set for May 31 to gather stakeholder input.

More than half the country has legalized marijuana use in one form or another.

Cannabis is just one focus of current clinical trials involving animals, with others focusing on treatments such as stem cells and monoclonal…

Online learning is one of many tools the AVMA provides to keep AVMA members and other veterinary professionals up to date on pressing clinical issues…

The AVMA House of Delegates (HOD) will meet January 10-11, and delegates are looking for member comments to inform their discussion of important…

The U.S. Food and Drug Administration (FDA) should provide regulatory clarity about expectations for the labeling, safety, and use of cannabis-derived…

In October, licensed veterinarians in the Silver State can recommend and administer hemp and CBD products, yet many questions remain about the drug’s…

Cannabis is becoming increasingly available for human recreational and medical use. Should veterinary practices monitor staff use of marijuana and…

With the publication of "Cannabis in Veterinary Medicine" by the AVMA, veterinarians now have a comprehensive new resource guide to the latest…

The American Society for the Prevention of Cruelty to Animals (ASPCA) Animal Poison Control Center (APCC) announced its annual list of top toxins for…

With the cannabidiol products market continuing to grow and after reviewing published scientific literature and information submitted to a public…

Food and Drug Administration officials warned four companies that they were illegally marketing cannabidiol products for animal use.